INTRODUCTION:Despite the importance of chemotherapy in the treatment of early stage triple negative breast cancer (TNBC). no one optimal regimen has been identified. We conducted a pilot trial comparing outcomes for the three most commonly used chemotherapy regimens to assess the feasibility of conducting a larger definitive trial. METHODS:Using integrated consent. https://herbsdailyes.shop/product-category/serrapeptase/
Randomised feasibility trial to compare three standard of care chemotherapy regimens for early stage triple-negative breast cancer (REaCT-TNBC trial).
Internet 6 minutes ago jzbrewghzqlog2Web Directory Categories
Web Directory Search
New Site Listings